MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma.
Authors: Cui XB; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China.; Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China., Peng H; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China., Li RR; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China., Mu JQ; First Department of Internal Medicine, Xinjiang Production and Construction Corp Hospital of Chinese People's Armed Police Force, Urumqi, China., Yang L; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China., Li N; Department of Oncology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China., Liu CX; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China., Hu JM; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China., Li SG; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China., Wei Y; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China., Laibo-Yin; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China., Zhou H; Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, Australia., Li F; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China.; Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China., Chen YZ; Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China.; The People's Hospital of Suzhou National Hi-Tech District, Suzhou, China.
Source: Oncotarget [Oncotarget] 2017 Sep 27; Vol. 8 (54), pp. 92454-92469. Date of Electronic Publication: 2017 Sep 27 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.21384